Ted W. Love
2016
In 2016, Ted W. Love earned a total compensation of $1.2M as President, Chief Executive Officer and Director at Global Blood Therapeutics, a 21% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $230,000 |
|---|---|
| Salary | $479,375 |
| Stock Awards | $507,838 |
| Other | $2,500 |
| Total | $1,219,713 |
Love received $507.8K in stock awards, accounting for 42% of the total pay in 2016.
Love also received $230K in non-equity incentive plan, $479.4K in salary and $2.5K in other compensation.
Rankings
In 2016, Ted W. Love's compensation ranked 7,296th out of 14,075 executives tracked by ExecPay. In other words, Love earned more than 48.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,296 out of 14,075 | 48th |
Division Manufacturing | 2,752 out of 5,489 | 50th |
Major group Chemicals And Allied Products | 900 out of 1,895 | 53rd |
Industry group Drugs | 699 out of 1,538 | 55th |
Industry Pharmaceutical Preparations | 556 out of 1,176 | 53rd |
Source: SEC filing on April 28, 2017.
Love's colleagues
We found three more compensation records of executives who worked with Ted W. Love at Global Blood Therapeutics in 2016.